Background Immunogenic cell death (ICD) is a specific form of regulated cell death induced
by a variety of stressors. During ICD, the dying cancer cells release damage-associated …

Immunogenic cell death (ICD) can activate adaptive immune response in the host with
normal immune system. Some synthetic chemotherapeutic drugs and natural compounds …

A growing body of evidence indicates that the anticancer effect of the immune system can be
activated by the immunogenic modulation of dying cancer cells. Cancer cell death, as a …

In the tumour microenvironment (TME), immunogenic cell death (ICD) plays a major role in
stimulating the dysfunctional antitumour immune system. Chronic exposure of damage …

Natural compounds act as immunoadjuvants as their therapeutic effects trigger cancer stress
response and release of damage-associated molecular patterns (DAMPs). These reactions …

Immunogenic cell death (ICD) is a regulated cell death (RCD) pathway. In response to
physical and chemical signals, tumor cells activate specific signaling pathways that stimulate …

Immunogenic cell death (ICD) has been a revolutionary modality in cancer treatment since it
kills primary tumors and prevents recurrent malignancy simultaneously. ICD represents a …

Inducing the immunogenic cell death (ICD) of cancer cells is an important method to improve
the immunogenicity of tumor cells for enhanced cancer immunotherapy. Therefore, we …

Immunotherapy has emerged as a promising cancer treatment option in recent years. In
immune “hot” tumors, characterized by abundant immune cell infiltration, immunotherapy …

As traditional strategies for cancer treatment, some chemotherapy agents, such as
doxorubicin, oxaliplatin, cyclophosphamide, bortezomib, and paclitaxel exert their anti-tumor …